Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14–15 September 2015

Williams, D.J., Archer, R., Archibald, P., Bantounas, I., Baptista, R., Barker, R., Barry, J., Bietrix, F., Blair, N., Braybrook, J., Campbell, J., Canham, M., Chandra, A., Foldes, G., Gilmanshin, R., Girard, M., Gorjup, E., Hewitt, Z., Hourd, P., Hyllner, J., Jesson, H., Kee, J., Kerby, J., Kotsopoulou, N., Kowalski, S., Leidel, C., Marshall, D., Masi, L., McCall, M., McCann, C., Medcalf, N., Moore, H., Ozawa, H., Pan, D., Parmar, M., Plant, A.L., Reinwald, Y. ORCID: 0000-0001-6733-605X, Sebastian, S., Stacey, G., Thomas, R.J., Thomas, D., Thurman-Newell, J., Turner, M., Vitillo, L., Wall, I., Wilson, A., Wolfrum, J., Yang, Y. and Zimmerman, H., 2016. Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14–15 September 2015. Regenerative Medicine, 11 (5), pp. 483-492. ISSN 1746-0751

[img]
Preview
Text
8826_Reinwald.pdf - Published version

Download (809kB) | Preview

Abstract

This paper summarizes the proceedings of a workshop held at Trinity Hall, Cambridge to discuss comparability and includes additional information and references to related information added subsequently to the workshop. Comparability is the need to demonstrate equivalence of product after a process change; a recent publication states that this ‘may be difficult for cell-based medicinal products’. Therefore a well-managed change process is required which needs access to good science and regulatory advice and developers are encouraged to seek help early. The workshop shared current thinking and best practice and allowed the definition of key research questions. The intent of this report is to summarize the key issues and the consensus reached on each of these by the expert delegates.

Item Type: Journal article
Publication Title: Regenerative Medicine
Creators: Williams, D.J., Archer, R., Archibald, P., Bantounas, I., Baptista, R., Barker, R., Barry, J., Bietrix, F., Blair, N., Braybrook, J., Campbell, J., Canham, M., Chandra, A., Foldes, G., Gilmanshin, R., Girard, M., Gorjup, E., Hewitt, Z., Hourd, P., Hyllner, J., Jesson, H., Kee, J., Kerby, J., Kotsopoulou, N., Kowalski, S., Leidel, C., Marshall, D., Masi, L., McCall, M., McCann, C., Medcalf, N., Moore, H., Ozawa, H., Pan, D., Parmar, M., Plant, A.L., Reinwald, Y., Sebastian, S., Stacey, G., Thomas, R.J., Thomas, D., Thurman-Newell, J., Turner, M., Vitillo, L., Wall, I., Wilson, A., Wolfrum, J., Yang, Y. and Zimmerman, H.
Publisher: Future Medicine Ltd.
Date: 12 July 2016
Volume: 11
Number: 5
ISSN: 1746-0751
Identifiers:
NumberType
10.2217/rme-2016-0053DOI
Divisions: Schools > School of Science and Technology
Record created by: Linda Sullivan
Date Added: 27 Jun 2017 09:55
Last Modified: 21 Jul 2017 13:56
URI: https://irep.ntu.ac.uk/id/eprint/31107

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year